On assessing survival benefit of immunotherapy using long‐term restricted mean survival time

DOI10.1002/SIM.9662MaRDI QIDQ61029FDOQ61029

Authors: Miki Horiguchi, Lu Tian, Hajime Uno 

Publication date: 18 January 2023

Published in: Statistics in Medicine (Search for Journal in Brave)

Cited In (1)

• survRM2adapt

This page was built for publication: On assessing survival benefit of immunotherapy using long‐term restricted mean survival time

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q61029)